Ardent Health Partners, LLC (ARDT) P/E Ratio History
Historical price-to-earnings valuation from 2024 to 2025
Loading P/E history...
Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of March 1, 2026, Ardent Health Partners, LLC (ARDT) trades at a price-to-earnings ratio of 5.9x, with a stock price of $9.39 and trailing twelve-month earnings per share of $1.45.
The current P/E is 54% below its 5-year average of 13.0x. Over the past five years, ARDT's P/E has ranged from a low of 7.3x to a high of 29.4x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 23.7x, ARDT trades at a 75% discount to its sector peers. The sector includes 224 companies with P/E ratios ranging from 0.0x to 184.4x.
The PEG ratio of 0.08 (P/E divided by 351% EPS growth) suggests the stock may be undervalued relative to its earnings growth. Peter Lynch popularized the rule that a PEG below 1.0 indicates an attractive entry point.
Relative to the broader market, ARDT trades at a notable discount to the S&P 500 median P/E of 26.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our ARDT DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
Peer Comparison
P/E metrics vs. Hospitals and inpatient facilities peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
HCAHCA Healthcare, Inc. | $118B | 18.7 | 0.89 | +29% |
THCTenet Healthcare Corporation | $21B | 15.5 | 0.47 | -53% |
ARDTArdent Health Partners, LLC | $1B | 5.9 | 0.08Best | +351%Best |
UHTUniversal Health Realty Income Trust | $605M | 34.3 | - | -9% |
CYHCommunity Health Systems, Inc. | $485M | 0.9Lowest | - | +197% |
AUNAAuna S.A. | $161M | 11.0 | - | +128% |
UHSUniversal Health Services, Inc. | $3M | 8.9 | 0.56 | +37% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
Historical P/E Data
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q3 | $13.25 | $1.50 | 8.8x | -32% | |
| FY2025 Q2 | Mon Jun 30 2025 00:00:00 GM | $13.66 | $1.86 | 7.3x | -44% |
| FY2025 Q1 | Mon Mar 31 2025 00:00:00 GM | $13.75 | $1.64 | 8.4x | -36% |
| FY2024 Q4 | $17.08 | $1.54 | 11.1x | -15% | |
| FY2024 Q3 | Mon Sep 30 2024 00:00:00 GM | $18.38 | $0.63 | 29.4x | +126% |
Average P/E for displayed period: 13.0x
See ARDT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ARDT Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare ARDT vs AGIO
See how ARDT stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is ARDT stock overvalued or undervalued?
ARDT trades at 5.9x P/E, below its 5-year average of 13.0x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does ARDT's valuation compare to peers?
Ardent Health Partners, LLC P/E of 5.9x compares to sector median of 23.7x. The discount suggests lower growth expectations or higher risk.
What is ARDT's PEG ratio?
ARDT PEG ratio is 0.08. Below 1.0 indicates valuation is supported by earnings growth rate. Historical P/E data spans 2024-2025.